Raghuram Selvaraju
Recent Articles
Four-Year Data on New Drug for Early AD Positive 04/09/2025
Long-term treatment with this small molecule seems feasible given its safety and tolerability profile, noted an H.C. Wainwright & Co. report.
LA Biotech Unveils New Patented Nicotinamide Riboside Chloride 07/15/2024
"The advent of NIAGEN IV could usher in a powerful new tailwind for revenue growth at ChromaDex Corp. (CDXC:NASDAQ)," noted an H.C. Wainwright & Co. report.
Biopharma's New Drug for COPD Likely to be Approved 04/22/2024
Characteristics of the Buy-rated company's lead candidate make it "an intriguing commercial prospect," noted an H.C. Wainwright & Co. report.
Due to permission requirements, not all quotes are shown.
